Indication
Advanced Liver Cancers
2 clinical trials
8 products
Clinical trial
A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)Status: Recruiting, Estimated PCD: 2025-12-27
Product
TiragolumabProduct
TocilizumabProduct
TPST-1120Product
RO7247669Product
ADG126Product
AtezolizumabProduct
BevacizumabClinical trial
A Clinical Study on TIL for the Treatment of Advanced Hepatobiliary-Pancreatic CancersStatus: Recruiting, Estimated PCD: 2024-09-25